2019 ANCO's ASCO Highlights in Renal Cell Carcinoma: What is the Role of Pembro/Avelumab+VEGF in mRCC and Checkpoint Inhibitors in Sarcomatoid RCC?
By
ANCO’s ASCO Highlights 2019
FEATURING
Sumit Shah
By
ANCO’s ASCO Highlights 2019
FEATURING
Sumit Shah
Login to view comments.
Click here to Login